{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:45:47Z","timestamp":1791974747526,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20743"],"award-info":[{"award-number":["U24A20743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32441094"],"award-info":[{"award-number":["32441094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402614"],"award-info":[{"award-number":["82402614"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2026QNPY04"],"award-info":[{"award-number":["2026QNPY04"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0501000"],"award-info":[{"award-number":["2023ZD0501000"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2309804"],"award-info":[{"award-number":["2024YFC2309804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","award":["PT2227440003"],"award-info":[{"award-number":["PT2227440003"]}],"id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.celrep.2026.118072","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:46:44Z","timestamp":1790448404000},"page":"118072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epstein-Barr virus gp350 neutralizing epitopes define distinct sites of vulnerability"],"prefix":"10.1016","volume":"45","author":[{"given":"Ge-Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Yu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Long","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Huang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Sheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Hao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Kai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-7420","authenticated-orcid":false,"given":"Cong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.118072_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mco2.32","article-title":"Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma","volume":"2","author":"Zhu","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.celrep.2026.118072_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.118072_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-026-10192-5","article-title":"A broadly protective antibody targeting gammaherpesvirus gB","volume":"653","author":"Sun","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.118072_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41586-025-09166-w","article-title":"R9AP is a common receptor for EBV infection in epithelial cells and B cells","volume":"644","author":"Li","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.118072_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11427-024-2766-0","article-title":"Research landmarks on the 60th anniversary of Epstein-Barr virus","volume":"68","author":"Zhong","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.celrep.2026.118072_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28793","article-title":"Anti-EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy","volume":"95","author":"Xie","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib7","article-title":"Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein-Barr Virus","volume":"38","author":"Sun","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celrep.2026.118072_bib8","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","article-title":"A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV","volume":"31","author":"Sun","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2026.118072_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2025.01.010","article-title":"Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350","volume":"58","author":"Joyce","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.118072_bib10","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1128\/JVI.01673-08","article-title":"Molecular basis of the interaction between complement receptor type 2 (CR2\/CD21) and Epstein-Barr virus glycoprotein gp350","volume":"82","author":"Young","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115168","article-title":"Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization","volume":"44","author":"Sun","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.118072_bib12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3390\/v14112372","article-title":"How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection","volume":"14","author":"Bu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2026.118072_bib13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.118072_bib14","doi-asserted-by":"crossref","DOI":"10.34133\/cancomm.0044","article-title":"Targeting Epstein-Barr Virus for Cancer Vaccines: Recent Advances and Future Directions","volume":"46","author":"Lin","year":"2026","journal-title":"Cancer Commun."},{"key":"10.1016\/j.celrep.2026.118072_bib15","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1099\/0022-1317-72-11-2747","article-title":"Mapping of the epitopes of Epstein-Barr virus gp350 using monoclonal antibodies and recombinant proteins expressed in Escherichia coli defines three antigenic determinants","volume":"72","author":"Zhang","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2019.07.026","article-title":"Identification of Multiple Potent Neutralizing and Non-Neutralizing Antibodies against Epstein-Barr Virus gp350 Protein with Potential for Clinical Application and as Reagents for Mapping Immunodominant Epitopes","volume":"536","author":"Mutsvunguma","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2026.118072_bib17","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1099\/0022-1317-74-10-2171","article-title":"Conformation-dependent recognition of baculovirus-expressed Epstein-Barr virus gp350 by a panel of monoclonal antibodies","volume":"74","author":"Zhang","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","article-title":"Human Complement Receptor Type 1\/CD35 is an Epstein-Barr Virus Receptor","volume":"3","author":"Ogembo","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.118072_bib19","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1128\/JVI.03269-14","article-title":"Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule","volume":"89","author":"Tanner","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib20","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.77.5.2979","article-title":"Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.118072_bib21","article-title":"Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection","volume":"5","author":"Zhao","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2026.118072_bib22","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1038\/s41467-021-26912-6","article-title":"A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.118072_bib23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/jvi.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/pathogens2010153","article-title":"Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases","volume":"2","author":"Fujiwara","year":"2013","journal-title":"Pathogens"},{"key":"10.1016\/j.celrep.2026.118072_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","article-title":"Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis","volume":"50","author":"Tanner","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.118072_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0042-6822(84)90102-8","article-title":"Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process","volume":"132","author":"Nemerow","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2026.118072_bib27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.137.4.1387","article-title":"Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system","volume":"137","author":"Tedder","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.118072_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/JVI.01953-09","article-title":"Epstein-Barr Viruses That Express a CD21 Antibody Provide Evidence that gp350\u2019s Functions Extend beyond B-Cell Surface Binding","volume":"84","author":"Busse","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib29","first-page":"160","article-title":"Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications","volume":"19","author":"Bjornevik","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.celrep.2026.118072_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-024-01774-8","article-title":"Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis","volume":"9","author":"Xie","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.118072_bib31","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nsmb1161","article-title":"Structure of the Epstein-Barr virus major envelope glycoprotein","volume":"13","author":"Szakonyi","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.118072_bib32","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/jvi.62.12.4452-4464.1988","article-title":"Soluble gp350\/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes","volume":"62","author":"Tanner","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.118072_bib33","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.118072_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106186","article-title":"Antibody-based strategies in HIV therapy","volume":"56","author":"Kufel","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.celrep.2026.118072_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/505912","article-title":"A Mouse Monoclonal Antibody against Epstein-Barr Virus Envelope Glycoprotein 350 Prevents Infection Both In Vitro and In Vivo","volume":"194","author":"Haque","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.118072_bib36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The Role of Antiviral Prophylaxis for the Prevention of Epstein\u2013Barr Virus\u2013Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.celrep.2026.118072_bib37","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1038\/srep06881","article-title":"Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus","volume":"4","author":"Audet","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.118072_bib38","article-title":"Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.118072_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-1759(00)00221-0","article-title":"Methods for the generation of chicken monoclonal antibody fragments by phage display","volume":"242","author":"Andris-Widhopf","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2026.118072_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2026.118072_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.celrep.2026.118072_bib42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.118072_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.118072_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S2059798318006551","article-title":"Real-space refinement in PHENIX for cryo-EM and crystallography","volume":"74","author":"Afonine","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2026.118072_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2026.118072_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.118072_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.118072_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2026.118072_bib49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.118072_bib50","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s11427-025-3102-7","article-title":"A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virus","volume":"69","author":"Liang","year":"2026","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.celrep.2026.118072_bib51","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.chembiol.2026.06.017","article-title":"A protective human antibody reveals a quaternary epitope on the Epstein-Barr virus fusion apparatus","volume":"33","author":"Zhao","year":"2026","journal-title":"Cell Chem. Biol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726011514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726011514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:56:10Z","timestamp":1791971770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726011514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2211124726011514"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.118072","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus gp350 neutralizing epitopes define distinct sites of vulnerability","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.118072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118072"}}